|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Heart Diseases | |||||
| Cardiovascular Diseases | |||||
| Tachycardia, Ventricular | |||||
| Ventricular Fibrillation | |||||
| Long QT Syndrome | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Syndrome | |||||
| Tachycardia | |||||
| 3 | More general conditions related to this trial | ||||
| Arrhythmias, Cardiac | |||||
| Cardiovascular Abnormalities | |||||
| Congenital Abnormalities | |||||
| Disease | |||||
| Heart Defects, Congenital | |||||
| Pathologic Processes | |||||
| 4 | Sponsors listed in this trial | ||||
| National Heart, Lung, and Blood Institute (NHLBI) | |||||